Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Learn how to use your skills to earn money that can lead to debt freedom. Turn your talents into financial gains.
16,558 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Kalshi locks billion valuation as a $1B round led by Coatue pushes the U.S. prediction market leader to a $22B valuat...
The AI boom has turned Nvidia and AMD into poster children for opportunity—and risk. This guide breaks down the signa...
Cursor, valued near $29 billion, stands at the center of a fast-moving AI coding boom. The company faces intense grow...
Bitcoin hovers around $70,000 after a brief pullback, as volatility eases and traders weigh whether this is the momen...
A contrarian take on the tech sell-off. Learn why durable AI and cloud trends could spark a rebound and how to positi...
A federal judge blocked the Trump administration from labeling Anthropic a supply chain risk, calling the move a poss...
In uncertain markets, the best consumer staples stocks stand out for their steady demand and reliable dividends. Lear...
Morgan Stanley expands into crypto trading on its E*TRADE platform, offering a lower-cost option for millions of reta...
SpaceX may steal headlines, but the real action for investors is in the earnings reports of BlackSky, Redwire, and Ro...
Two funds track the same Nasdaq-100 index, but a lower expense ratio gives Invesco NASDAQ 100 ETF a quiet advantage f...
NVIDIA posted blockbuster results that reinforce its AI data center leadership, but the stock faces a rocky road as h...